Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cannabis | 12 | 2024 | 444 | 4.170 |
Why?
|
Cannabinoids | 7 | 2021 | 173 | 2.900 |
Why?
|
Marijuana Abuse | 6 | 2020 | 412 | 1.800 |
Why?
|
Marijuana Smoking | 4 | 2020 | 259 | 1.560 |
Why?
|
Muscle Spasticity | 3 | 2017 | 158 | 1.470 |
Why?
|
Hallucinogens | 2 | 2022 | 208 | 1.200 |
Why?
|
Legislation, Drug | 4 | 2022 | 216 | 0.950 |
Why?
|
Opioid-Related Disorders | 7 | 2022 | 2188 | 0.880 |
Why?
|
Buprenorphine | 3 | 2022 | 661 | 0.790 |
Why?
|
N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2022 | 69 | 0.760 |
Why?
|
Cocaine-Related Disorders | 11 | 2008 | 461 | 0.620 |
Why?
|
Cannabidiol | 1 | 2020 | 123 | 0.590 |
Why?
|
Psychiatry | 2 | 2021 | 1714 | 0.520 |
Why?
|
Opiate Substitution Treatment | 2 | 2022 | 446 | 0.510 |
Why?
|
Naloxone | 2 | 2015 | 371 | 0.500 |
Why?
|
Government Regulation | 1 | 2019 | 525 | 0.460 |
Why?
|
Drug Industry | 4 | 2009 | 793 | 0.420 |
Why?
|
Burnout, Professional | 1 | 2021 | 712 | 0.420 |
Why?
|
Subclavian Steal Syndrome | 1 | 2012 | 20 | 0.400 |
Why?
|
Emergency Medicine | 1 | 2021 | 1222 | 0.400 |
Why?
|
Tobacco Use Disorder | 3 | 2013 | 710 | 0.380 |
Why?
|
Alcoholism | 3 | 2013 | 1993 | 0.360 |
Why?
|
DiGeorge Syndrome | 1 | 2012 | 187 | 0.350 |
Why?
|
Nicotine | 2 | 2013 | 681 | 0.350 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2012 | 216 | 0.350 |
Why?
|
Neuralgia | 1 | 2015 | 620 | 0.310 |
Why?
|
Substance-Related Disorders | 5 | 2024 | 4453 | 0.300 |
Why?
|
Phosphodiesterase 5 Inhibitors | 1 | 2009 | 104 | 0.300 |
Why?
|
Drug Approval | 1 | 2015 | 817 | 0.300 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2009 | 213 | 0.300 |
Why?
|
Psychotherapy | 5 | 2022 | 1656 | 0.290 |
Why?
|
Substance Abuse Detection | 3 | 2020 | 301 | 0.290 |
Why?
|
Sumatriptan | 1 | 2007 | 66 | 0.290 |
Why?
|
Risk | 2 | 2017 | 9642 | 0.290 |
Why?
|
Naproxen | 1 | 2007 | 101 | 0.280 |
Why?
|
Sleep Apnea Syndromes | 1 | 2015 | 981 | 0.280 |
Why?
|
Prolactin | 5 | 2008 | 626 | 0.280 |
Why?
|
Amphetamine-Related Disorders | 1 | 2007 | 81 | 0.270 |
Why?
|
Marketing | 1 | 2008 | 224 | 0.260 |
Why?
|
Gift Giving | 1 | 2006 | 76 | 0.250 |
Why?
|
Anxiety Disorders | 1 | 2017 | 2754 | 0.250 |
Why?
|
Combined Modality Therapy | 5 | 2022 | 8559 | 0.250 |
Why?
|
Biological Therapy | 1 | 2007 | 140 | 0.250 |
Why?
|
Serotonin | 4 | 2008 | 1047 | 0.250 |
Why?
|
Marketing of Health Services | 1 | 2006 | 151 | 0.240 |
Why?
|
Biomedical Research | 2 | 2019 | 3463 | 0.240 |
Why?
|
Vomiting | 2 | 2020 | 655 | 0.230 |
Why?
|
5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2004 | 28 | 0.230 |
Why?
|
Humans | 62 | 2024 | 768451 | 0.230 |
Why?
|
Adolescent Behavior | 1 | 2013 | 1192 | 0.230 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2022 | 4636 | 0.230 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2004 | 46 | 0.220 |
Why?
|
Interview, Psychological | 1 | 2007 | 812 | 0.220 |
Why?
|
Vasoconstrictor Agents | 1 | 2007 | 658 | 0.220 |
Why?
|
Nausea | 2 | 2019 | 682 | 0.220 |
Why?
|
Health Surveys | 2 | 2015 | 4056 | 0.220 |
Why?
|
Physicians | 1 | 2021 | 4615 | 0.220 |
Why?
|
Smoking Cessation | 2 | 2013 | 2079 | 0.220 |
Why?
|
Conflict of Interest | 1 | 2008 | 556 | 0.220 |
Why?
|
Substance Abuse Treatment Centers | 2 | 2014 | 167 | 0.210 |
Why?
|
Analgesics, Opioid | 6 | 2022 | 3837 | 0.210 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1949 | 0.210 |
Why?
|
Narcotic Antagonists | 4 | 2015 | 590 | 0.210 |
Why?
|
Serotonin Receptor Agonists | 4 | 2008 | 151 | 0.200 |
Why?
|
Membrane Transport Proteins | 3 | 2003 | 1036 | 0.200 |
Why?
|
Cyclooxygenase 2 Inhibitors | 3 | 2009 | 321 | 0.200 |
Why?
|
Internship and Residency | 2 | 2021 | 5952 | 0.200 |
Why?
|
Lactones | 3 | 2009 | 316 | 0.200 |
Why?
|
Epilepsy | 1 | 2017 | 3324 | 0.200 |
Why?
|
Sulfones | 3 | 2009 | 448 | 0.190 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 5 | 2008 | 328 | 0.190 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 900 | 0.190 |
Why?
|
Policy | 2 | 2022 | 515 | 0.190 |
Why?
|
Vitamin B 12 | 1 | 2004 | 527 | 0.180 |
Why?
|
Ambulatory Care Facilities | 1 | 2007 | 941 | 0.180 |
Why?
|
Ethics, Medical | 1 | 2006 | 785 | 0.180 |
Why?
|
Paroxetine | 5 | 2008 | 181 | 0.180 |
Why?
|
Endocarditis | 1 | 2024 | 355 | 0.170 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2020 | 628 | 0.140 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2279 | 0.140 |
Why?
|
Membrane Glycoproteins | 3 | 2003 | 3713 | 0.140 |
Why?
|
Defense Mechanisms | 1 | 2017 | 180 | 0.140 |
Why?
|
Diabetic Neuropathies | 1 | 2021 | 411 | 0.140 |
Why?
|
Human Development | 1 | 2017 | 123 | 0.130 |
Why?
|
Pilot Projects | 4 | 2017 | 8730 | 0.130 |
Why?
|
Analgesics | 2 | 2021 | 1070 | 0.130 |
Why?
|
Canada | 2 | 2019 | 2143 | 0.130 |
Why?
|
Piperazines | 4 | 2008 | 2546 | 0.130 |
Why?
|
Hypnotics and Sedatives | 1 | 2004 | 1188 | 0.130 |
Why?
|
Carrier Proteins | 4 | 2003 | 4948 | 0.130 |
Why?
|
Behavior, Addictive | 2 | 2019 | 467 | 0.130 |
Why?
|
Disease Progression | 1 | 2013 | 13655 | 0.130 |
Why?
|
Nerve Tissue Proteins | 3 | 2003 | 4417 | 0.120 |
Why?
|
Mental Health Services | 1 | 2007 | 1732 | 0.120 |
Why?
|
Family Relations | 1 | 2017 | 318 | 0.120 |
Why?
|
Cotinine | 2 | 2013 | 207 | 0.120 |
Why?
|
Social Adjustment | 1 | 2017 | 636 | 0.120 |
Why?
|
Migraine Disorders | 1 | 2007 | 1713 | 0.120 |
Why?
|
District of Columbia | 1 | 2014 | 159 | 0.120 |
Why?
|
Blood Platelets | 5 | 2008 | 2485 | 0.120 |
Why?
|
Workplace | 1 | 2020 | 872 | 0.110 |
Why?
|
Syndrome | 1 | 2020 | 3278 | 0.110 |
Why?
|
Alcoholics Anonymous | 1 | 2013 | 33 | 0.110 |
Why?
|
Wasting Syndrome | 1 | 2014 | 96 | 0.110 |
Why?
|
Adult | 24 | 2024 | 223542 | 0.110 |
Why?
|
Anesthesia | 1 | 2024 | 1596 | 0.110 |
Why?
|
Time | 1 | 2015 | 546 | 0.110 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 8051 | 0.110 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1013 | 0.100 |
Why?
|
Antiemetics | 1 | 2014 | 188 | 0.100 |
Why?
|
Residential Treatment | 1 | 2013 | 112 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 10358 | 0.100 |
Why?
|
Carbon Monoxide | 2 | 2013 | 551 | 0.100 |
Why?
|
Receptors, Serotonin | 2 | 2003 | 209 | 0.100 |
Why?
|
State Government | 1 | 2015 | 389 | 0.100 |
Why?
|
Norwood Procedures | 1 | 2014 | 192 | 0.100 |
Why?
|
Bipolar Disorder | 2 | 2012 | 5124 | 0.100 |
Why?
|
Delirium | 1 | 2004 | 1694 | 0.100 |
Why?
|
Pyridines | 1 | 2004 | 2888 | 0.100 |
Why?
|
Female | 26 | 2024 | 396943 | 0.100 |
Why?
|
Behavior Therapy | 1 | 2017 | 885 | 0.100 |
Why?
|
Counseling | 2 | 2013 | 1548 | 0.090 |
Why?
|
Subclavian Artery | 1 | 2012 | 133 | 0.090 |
Why?
|
United States | 7 | 2021 | 73121 | 0.090 |
Why?
|
Multiple Sclerosis | 2 | 2017 | 3245 | 0.090 |
Why?
|
Health Education | 1 | 2018 | 1059 | 0.090 |
Why?
|
Narcotics | 1 | 2013 | 337 | 0.090 |
Why?
|
Withholding Treatment | 1 | 2015 | 621 | 0.090 |
Why?
|
Administration, Cutaneous | 1 | 2013 | 716 | 0.090 |
Why?
|
Polymorphism, Genetic | 3 | 2007 | 4249 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2015 | 713 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2339 | 0.090 |
Why?
|
Mood Disorders | 1 | 2017 | 1128 | 0.090 |
Why?
|
Alcohol-Related Disorders | 1 | 2012 | 243 | 0.090 |
Why?
|
Patient Readmission | 1 | 2024 | 3308 | 0.090 |
Why?
|
Safety-Based Drug Withdrawals | 1 | 2009 | 36 | 0.080 |
Why?
|
Male | 26 | 2024 | 364781 | 0.080 |
Why?
|
Neurodegenerative Diseases | 1 | 2019 | 1095 | 0.080 |
Why?
|
Transcranial Magnetic Stimulation | 1 | 2019 | 1489 | 0.080 |
Why?
|
United States Food and Drug Administration | 2 | 2015 | 1669 | 0.080 |
Why?
|
Impulsive Behavior | 2 | 2019 | 350 | 0.080 |
Why?
|
Cycloserine | 1 | 2009 | 118 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2015 | 13026 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2004 | 3278 | 0.080 |
Why?
|
Ramipril | 1 | 2009 | 102 | 0.080 |
Why?
|
Deception | 1 | 2008 | 101 | 0.070 |
Why?
|
Sex Distribution | 1 | 2013 | 2286 | 0.070 |
Why?
|
Seizures | 1 | 2020 | 2996 | 0.070 |
Why?
|
Age of Onset | 2 | 2013 | 3342 | 0.070 |
Why?
|
Tablets | 1 | 2007 | 149 | 0.070 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 888 | 0.070 |
Why?
|
Ethics Committees, Research | 1 | 2008 | 196 | 0.070 |
Why?
|
Carbolines | 1 | 2009 | 296 | 0.070 |
Why?
|
Adolescent | 5 | 2021 | 89168 | 0.070 |
Why?
|
Amlodipine | 1 | 2007 | 84 | 0.070 |
Why?
|
Renin | 1 | 2009 | 642 | 0.070 |
Why?
|
Analysis of Variance | 2 | 2013 | 6242 | 0.070 |
Why?
|
GABA Agonists | 1 | 2007 | 104 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2017 | 2665 | 0.070 |
Why?
|
Pituitary Gland, Anterior | 1 | 2006 | 142 | 0.070 |
Why?
|
Behavior | 2 | 2006 | 545 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2009 | 495 | 0.060 |
Why?
|
Disclosure | 2 | 2008 | 750 | 0.060 |
Why?
|
Ambulatory Care | 3 | 2013 | 2780 | 0.060 |
Why?
|
Aggression | 3 | 2006 | 750 | 0.060 |
Why?
|
Cross-Over Studies | 2 | 2009 | 2103 | 0.060 |
Why?
|
Research Support as Topic | 2 | 2008 | 699 | 0.060 |
Why?
|
Nicotinic Agonists | 1 | 2007 | 266 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2014 | 1677 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5103 | 0.060 |
Why?
|
Sex Factors | 2 | 2013 | 10647 | 0.060 |
Why?
|
Authorship | 1 | 2008 | 287 | 0.060 |
Why?
|
Comorbidity | 2 | 2017 | 10601 | 0.060 |
Why?
|
Medicaid | 1 | 2018 | 2843 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2021 | 65409 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2533 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1813 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2010 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 24311 | 0.060 |
Why?
|
Drive | 1 | 2003 | 34 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5096 | 0.060 |
Why?
|
Insurance Coverage | 1 | 2015 | 1946 | 0.060 |
Why?
|
Patient Dropouts | 2 | 2002 | 411 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2705 | 0.050 |
Why?
|
Public Health | 1 | 2016 | 2693 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 26351 | 0.050 |
Why?
|
Cardiovascular System | 1 | 2009 | 838 | 0.050 |
Why?
|
Age Factors | 2 | 2013 | 18478 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1518 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2013 | 5308 | 0.050 |
Why?
|
Mental Health | 1 | 2016 | 3271 | 0.050 |
Why?
|
Young Adult | 4 | 2017 | 60045 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8753 | 0.050 |
Why?
|
Risk-Taking | 1 | 2007 | 1041 | 0.050 |
Why?
|
Risk Factors | 3 | 2020 | 74915 | 0.050 |
Why?
|
Valproic Acid | 1 | 2004 | 443 | 0.050 |
Why?
|
Drug Combinations | 1 | 2007 | 2079 | 0.050 |
Why?
|
Publishing | 1 | 2008 | 836 | 0.050 |
Why?
|
Mental Disorders | 1 | 2020 | 6879 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2009 | 12450 | 0.040 |
Why?
|
Middle Aged | 8 | 2024 | 223418 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1207 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8908 | 0.040 |
Why?
|
Hydrocodone | 1 | 1999 | 48 | 0.040 |
Why?
|
Cinnamates | 1 | 1999 | 59 | 0.040 |
Why?
|
Pregnancy | 1 | 2020 | 30179 | 0.040 |
Why?
|
Prospective Studies | 2 | 2017 | 54914 | 0.040 |
Why?
|
Logistic Models | 1 | 2013 | 13324 | 0.040 |
Why?
|
Intracranial Pressure | 1 | 2000 | 325 | 0.040 |
Why?
|
Receptors, Opioid, mu | 1 | 1999 | 171 | 0.040 |
Why?
|
Quality of Life | 2 | 2019 | 13497 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10784 | 0.040 |
Why?
|
Drug Therapy, Combination | 1 | 2007 | 6320 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2014 | 4713 | 0.040 |
Why?
|
Seasons | 1 | 2003 | 1526 | 0.030 |
Why?
|
Blood Pressure | 2 | 2009 | 8538 | 0.030 |
Why?
|
Radioligand Assay | 2 | 2008 | 366 | 0.030 |
Why?
|
Astrocytoma | 1 | 2000 | 780 | 0.030 |
Why?
|
Urban Population | 1 | 2003 | 2047 | 0.030 |
Why?
|
Patient Compliance | 2 | 2003 | 2696 | 0.030 |
Why?
|
Electroconvulsive Therapy | 1 | 2000 | 502 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2007 | 2913 | 0.030 |
Why?
|
Motivation | 2 | 2020 | 2034 | 0.030 |
Why?
|
Outpatients | 1 | 2002 | 1607 | 0.030 |
Why?
|
Heroin | 1 | 2014 | 120 | 0.030 |
Why?
|
Brain | 2 | 2019 | 27438 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2004 | 1923 | 0.030 |
Why?
|
Injections, Intraventricular | 2 | 2007 | 227 | 0.030 |
Why?
|
Infant | 2 | 2014 | 36497 | 0.030 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2004 | 1401 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2008 | 1144 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1728 | 0.030 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2012 | 303 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36840 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2024 | 3629 | 0.020 |
Why?
|
Reference Values | 3 | 2003 | 4941 | 0.020 |
Why?
|
Aged | 5 | 2024 | 171520 | 0.020 |
Why?
|
North America | 1 | 2014 | 1292 | 0.020 |
Why?
|
Cocaine | 2 | 2006 | 960 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2427 | 0.020 |
Why?
|
Cardiac Surgical Procedures | 1 | 2024 | 3682 | 0.020 |
Why?
|
Myocardial Infarction | 1 | 2009 | 11515 | 0.020 |
Why?
|
Severity of Illness Index | 4 | 2008 | 15965 | 0.020 |
Why?
|
Breath Tests | 1 | 2009 | 300 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3438 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12096 | 0.020 |
Why?
|
Tritium | 1 | 2008 | 707 | 0.020 |
Why?
|
Radioimmunoassay | 1 | 2008 | 862 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2009 | 359 | 0.020 |
Why?
|
Binding Sites | 2 | 2008 | 6030 | 0.020 |
Why?
|
Extinction, Psychological | 1 | 2009 | 371 | 0.020 |
Why?
|
Self Administration | 1 | 2007 | 387 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2014 | 1894 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2008 | 354 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2006 | 6091 | 0.020 |
Why?
|
Prognosis | 2 | 2002 | 30028 | 0.010 |
Why?
|
Cues | 1 | 2009 | 884 | 0.010 |
Why?
|
Palliative Care | 1 | 2019 | 3644 | 0.010 |
Why?
|
Hospitalization | 1 | 2004 | 10845 | 0.010 |
Why?
|
Reoperation | 1 | 2014 | 4342 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6537 | 0.010 |
Why?
|
Receptors, Drug | 1 | 2003 | 157 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7451 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2014 | 15460 | 0.010 |
Why?
|
Philadelphia | 1 | 2003 | 271 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3771 | 0.010 |
Why?
|
Child Development | 1 | 2014 | 2328 | 0.010 |
Why?
|
Depressive Disorder, Major | 1 | 2000 | 4816 | 0.010 |
Why?
|
DNA Primers | 1 | 2006 | 2826 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9687 | 0.010 |
Why?
|
Echocardiography | 1 | 2014 | 5043 | 0.010 |
Why?
|
Personality Assessment | 1 | 2003 | 649 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2014 | 7134 | 0.010 |
Why?
|
Pennsylvania | 1 | 2002 | 616 | 0.010 |
Why?
|
Receptors, Dopamine | 1 | 2002 | 296 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14766 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2014 | 3291 | 0.010 |
Why?
|
Length of Stay | 1 | 2014 | 6521 | 0.010 |
Why?
|
Time Factors | 2 | 2014 | 40271 | 0.010 |
Why?
|
Genotype | 2 | 2006 | 13047 | 0.010 |
Why?
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 1999 | 19 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2014 | 12561 | 0.010 |
Why?
|
Gene Frequency | 1 | 2006 | 3615 | 0.010 |
Why?
|
Membranes | 1 | 1999 | 164 | 0.010 |
Why?
|
Enkephalins | 1 | 1999 | 139 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3858 | 0.010 |
Why?
|
Personality Inventory | 1 | 2002 | 1019 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2000 | 624 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2000 | 9182 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 1999 | 363 | 0.010 |
Why?
|
Databases, Factual | 1 | 2014 | 8081 | 0.010 |
Why?
|
Regression Analysis | 1 | 2008 | 6353 | 0.010 |
Why?
|
Central Nervous System Stimulants | 1 | 2006 | 1180 | 0.010 |
Why?
|
Neostriatum | 1 | 1999 | 247 | 0.010 |
Why?
|
Neurologic Examination | 1 | 2000 | 916 | 0.010 |
Why?
|
Animals | 2 | 2007 | 169418 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20231 | 0.010 |
Why?
|
Brain Edema | 1 | 2000 | 608 | 0.010 |
Why?
|
Heart Rate | 1 | 2007 | 4218 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 81834 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5803 | 0.010 |
Why?
|
Morphine | 1 | 1999 | 658 | 0.010 |
Why?
|
Cattle | 1 | 1999 | 3830 | 0.010 |
Why?
|
Reaction Time | 1 | 1999 | 2102 | 0.010 |
Why?
|
Ligands | 1 | 1999 | 3281 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15880 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21552 | 0.010 |
Why?
|
Patient Care Team | 1 | 2000 | 2526 | 0.000 |
Why?
|
Pain Measurement | 1 | 1999 | 3577 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2006 | 22293 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 2004 | 39430 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20762 | 0.000 |
Why?
|
Mice | 1 | 1999 | 82045 | 0.000 |
Why?
|